ValueAct Capital has made its first investment in Japan. The San Francisco-based activist firm, which manages more than $14 billion, said it has taken a stake of more than 5 percent in Olympus Corp., according to a press release. The company best known for its cameras actually gets 80 percent of its revenue from endoscopes and other medical-imaging technology, according to the Wall Street Journal.
